Perspectives

4/17/2025 7:48:26 PM

The High Cost of Trust: What Pharmacies Must Learn from the Rise of Counterfeit GLP-1 Product Sales

By Dae Lee Natalie Crow

The market for GLP-1 products—such as Ozempic, Wegovy, and Mounjaro—has exploded, driven by demand for both weight management and...

4/8/2025 4:30:25 PM

By Dae Lee

In recent years, pharmacies have come under increasing scrutiny from the Drug Enforcement Administration (DEA), wholesalers, and...

4/4/2025 2:23:37 PM

By Dae Lee

In March 2025, the U.S. District Court for the District of Minnesota dismissed a proposed class-action lawsuit filed against Wells Fargo...

3/28/2025 3:50:08 PM

By Dae Lee

The independent pharmacy space has seen a significant uptick in transactional activity over the past few years. Whether driven by...

3/27/2025 3:56:17 PM

By Dae Lee

The first quarter of 2025 has made one thing clear: Pharmacy Benefit Managers (PBMs) have ramped up their enforcement playbook, catching...

3/19/2025 3:09:23 PM

By Dae Lee

The Medicaid Drug Rebate Program (MDRP) is a cornerstone of pharmaceutical pricing regulation, requiring drug manufacturers to provide...

3/18/2025 7:18:19 PM

By Dae Lee

JPMorgan Chase & Co. is the latest major corporation to face a class action lawsuit from employees alleging mismanagement of their...

3/12/2025 1:59:49 PM

By Dae Lee

Florida’s Prescription Drug Reform Act is one of the most aggressive state-level PBM reform laws enacted in response to the Supreme...